NASDAQ:AZN

AstraZeneca Stock Forecast, Price & News

$52.26
-0.45 (-0.85 %)
(As of 04/23/2021 01:45 PM ET)
Add
Compare
Today's Range
$52.18
Now: $52.26
$52.75
50-Day Range
$47.16
MA: $49.61
$53.11
52-Week Range
$46.48
Now: $52.26
$64.94
Volume385,800 shs
Average Volume11.15 million shs
Market Capitalization$137.16 billion
P/E Ratio54.44
Dividend Yield3.50%
Beta0.55
AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company's marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; and AliveCor, Inc. to develop non-invasive potassium monitoring solutions. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
AstraZeneca logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AZN
CUSIPN/A
CIKN/A
Phone44 20 3749 5000
Employees76,100
Year Founded1999

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$24.38 billion
Cash Flow$3.22 per share
Book Value$5.56 per share

Profitability

Net Income$1.34 billion

Miscellaneous

Outstanding Shares2,624,593,000
Market Cap$137.16 billion
Next Earnings Date4/30/2021 (Confirmed)
OptionableOptionable

Headlines

3 Big-Time Biotech Stocks to Buy Now (AZN)
April 2, 2021 |  marketbeat.com
See More Headlines

MarketRank

Overall MarketRank

2.13 out of 5 stars

Medical Sector

34th out of 2,025 stocks

Pharmaceutical Preparations Industry

12th out of 772 stocks

Analyst Opinion: 4.3Community Rank: 2.8Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
$52.26
-0.45 (-0.85 %)
(As of 04/23/2021 01:45 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AZN News and Ratings via Email

Sign-up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AstraZeneca (NASDAQ:AZN) Frequently Asked Questions

Is AstraZeneca a buy right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings, 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AstraZeneca stock.
View analyst ratings for AstraZeneca
or view top-rated stocks.

What stocks does MarketBeat like better than AstraZeneca?

Wall Street analysts have given AstraZeneca a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AstraZeneca wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is AstraZeneca's next earnings date?

AstraZeneca is scheduled to release its next quarterly earnings announcement on Friday, April 30th 2021.
View our earnings forecast for AstraZeneca
.

How can I listen to AstraZeneca's earnings call?

AstraZeneca will be holding an earnings conference call on Friday, April 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were AstraZeneca's earnings last quarter?

AstraZeneca PLC (NASDAQ:AZN) posted its earnings results on Wednesday, February, 10th. The company reported $0.54 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.68 by $0.14. The company earned $7.41 billion during the quarter, compared to analyst estimates of $6.98 billion. AstraZeneca had a trailing twelve-month return on equity of 37.23% and a net margin of 9.65%.
View AstraZeneca's earnings history
.

How has AstraZeneca's stock price been impacted by COVID-19 (Coronavirus)?

AstraZeneca's stock was trading at $44.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AZN shares have increased by 17.1% and is now trading at $52.20.
View which stocks have been most impacted by COVID-19
.

How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?

AstraZeneca announced a semi-annual dividend on Friday, February 12th. Stockholders of record on Friday, February 26th will be paid a dividend of $0.95 per share on Monday, March 29th. This represents a yield of 2.7%. The ex-dividend date of this dividend is Thursday, February 25th. This is a boost from AstraZeneca's previous semi-annual dividend of $0.45.
View AstraZeneca's dividend history
.

Is AstraZeneca a good dividend stock?

AstraZeneca pays an annual dividend of $1.86 per share and currently has a dividend yield of 3.50%. The dividend payout ratio of AstraZeneca is 106.29%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, AstraZeneca will have a dividend payout ratio of 71.54% next year. This indicates that AstraZeneca will be able to sustain or increase its dividend.
View AstraZeneca's dividend history.

When did AstraZeneca's stock split? How did AstraZeneca's stock split work?

AstraZeneca's stock split on Monday, July 27th 2015. The 2-1 split was announced on Friday, June 26th 2015. The newly created shares were issued to shareholders after the closing bell on Friday, July 24th 2015. An investor that had 100 shares of AstraZeneca stock prior to the split would have 200 shares after the split.

What guidance has AstraZeneca issued on next quarter's earnings?

AstraZeneca updated its FY 2021 Pre-Market earnings guidance on Thursday, February, 11th. The company provided EPS guidance of 4.75-5.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.95.

What price target have analysts set for AZN?

15 equities research analysts have issued 12-month price targets for AstraZeneca's shares. Their forecasts range from $60.00 to $175.00. On average, they anticipate AstraZeneca's share price to reach $89.50 in the next twelve months. This suggests a possible upside of 71.5% from the stock's current price.
View analysts' price targets for AstraZeneca
or view top-rated stocks among Wall Street analysts.

Who are AstraZeneca's key executives?

AstraZeneca's management team includes the following people:
  • Mr. Pascal Soriot D.V.M., M.B.A., CEO & Exec. Director (Age 62)
  • Mr. Marc Dunoyer, CFO & Exec. Director (Age 69)
  • Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 50) (LinkedIn Profile)
  • Thomas Kudsk Larsen, Head of Investor Relations
  • Mr. Jefrey Pott, Exec. VP of HR & Gen. Counsel
  • Ms. Katarina Ageborg, Exec. VP of Sustainability & Chief Compliance Officer
  • Dr. Menelas Pangalos, Exec. Vice-Pres of BioPharmaceuticals R&D
  • Dr. Ruud Dobber, Exec. Vice-Pres of BioPharmaceuticals Bus. Unit (LinkedIn Profile)
  • Dr. Susan Mary Galbraith, Sr. VP and Head of Research, Early Devel. & Oncology R&D (Age 55)
  • Dr. David B. Goldstein Ph.D., Chief Adviser

What is Pascal Soriot's approval rating as AstraZeneca's CEO?

1,263 employees have rated AstraZeneca CEO Pascal Soriot on Glassdoor.com. Pascal Soriot has an approval rating of 98% among AstraZeneca's employees. This puts Pascal Soriot in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of AstraZeneca's key competitors?

What other stocks do shareholders of AstraZeneca own?

What is AstraZeneca's stock symbol?

AstraZeneca trades on the NASDAQ under the ticker symbol "AZN."

Who are AstraZeneca's major shareholders?

AstraZeneca's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vigilant Capital Management LLC (0.01%), Park National Corp OH (0.01%), James Investment Research Inc. (0.01%), BOKF NA (0.01%), Private Advisor Group LLC (0.00%) and Timber Creek Capital Management LLC (0.00%).
View institutional ownership trends for AstraZeneca
.

Which major investors are selling AstraZeneca stock?

AZN stock was sold by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, BLB&B Advisors LLC, FDx Advisors Inc., James Investment Research Inc., Great Valley Advisor Group Inc., FDx Advisors Inc., Crossmark Global Holdings Inc., and TIAA FSB.
View insider buying and selling activity for AstraZeneca
or view top insider-selling stocks.

Which major investors are buying AstraZeneca stock?

AZN stock was acquired by a variety of institutional investors in the last quarter, including Private Advisor Group LLC, Quattro Financial Advisors LLC, Vigilant Capital Management LLC, Marotta Asset Management, Venturi Wealth Management LLC, LVW Advisors LLC, Reilly Financial Advisors LLC, and Guild Investment Management Inc..
View insider buying and selling activity for AstraZeneca
or or view top insider-buying stocks.

How do I buy shares of AstraZeneca?

Shares of AZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AstraZeneca's stock price today?

One share of AZN stock can currently be purchased for approximately $52.20.

How much money does AstraZeneca make?

AstraZeneca has a market capitalization of $137.00 billion and generates $24.38 billion in revenue each year. The company earns $1.34 billion in net income (profit) each year or $1.75 on an earnings per share basis.

How many employees does AstraZeneca have?

AstraZeneca employs 76,100 workers across the globe.

Does AstraZeneca have any subsidiaries?

The following companies are subsidiares of AstraZeneca: AAPM Sar, AZ Reinsurance Limited, AZ-Mont Insurance Company, AZENCO2 Limited, AZENCO4 Limited, Acerta Pharma B.V., Acerta Pharma LLC, AcertaPharma, Aktiebolaget Hassle, Alexion Pharmaceuticals, Almirall, AlphaCore Pharma, Amylin Ohio LLC, Amylin Pharmaceuticals LLC, Archigen Biotech Limited, Ardea Biosciences, Ardea Biosciences Limited, Arrow Therapeutics, Arrow Therapeutics Limited, Aspire Therapeutics B.V., Astra Alpha Produtos Farmaceuticos Lda, Astra Export & Trading Aktiebolag, Astra Lakemedel Aktiebolag, Astra Pharmaceuticals Limited, Astra Tech International Aktiebolag, AstraPharm, AstraZeneca (Israel) Ltd, AstraZeneca (Thailand) Limited, AstraZeneca (Wuxi) Trading Co. Ltd, AstraZeneca A/S, AstraZeneca AB, AstraZeneca AG, AstraZeneca AS, AstraZeneca Asia-Pacific Business Services Sdn Bhd, AstraZeneca B.V., AstraZeneca BioVentureHub AB, AstraZeneca Biotech AB, AstraZeneca Bulgaria EOOD, AstraZeneca CAMCAR Costa Rica S.A., AstraZeneca CAMCAR S.A., AstraZeneca Canada Inc., AstraZeneca China UK Limited, AstraZeneca Collaboration Ventures LLC, AstraZeneca Colombia S.A.S., AstraZeneca Continent B.V., AstraZeneca Czech Republic s.r.o., AstraZeneca Death In Service, AstraZeneca Dunkerque Production SCS, AstraZeneca Eesti OÜ, AstraZeneca Egypt for Pharmaceutical Industries JSC, AstraZeneca Egypt for Trading LLC, AstraZeneca Employee Share Trust Limited, AstraZeneca FZ-LLC, AstraZeneca Farmaceutica Chile Limitada, AstraZeneca Farmaceutica Holding Spain S.A., AstraZeneca Farmaceutica Spain S.A., AstraZeneca Finance Limited, AstraZeneca Finance S.A.S., AstraZeneca Gamma B.V., AstraZeneca GmbH, AstraZeneca Health Care Division S.A. de C.V., AstraZeneca Holding Aktiebolag, AstraZeneca Holding France S.A.S., AstraZeneca Holding GmbH, AstraZeneca Holdings B.V., AstraZeneca Holdings Pty Limited, AstraZeneca Hong Kong Limited, AstraZeneca Ilac Sanayi ve Ticaret Limited Sirketi, AstraZeneca India Private Limited, AstraZeneca Industries LLC, AstraZeneca Intermediate Holdings Limited, AstraZeneca International Holdings Aktiebolag, AstraZeneca Investment (China) Co. Ltd, AstraZeneca Investments Limited, AstraZeneca Japan Limited, AstraZeneca Jota B.V., AstraZeneca K.K., AstraZeneca Kft, AstraZeneca Korea Co. Ltd, AstraZeneca Latvija SIA, AstraZeneca Lietuva UAB, AstraZeneca Limited, AstraZeneca Luxembourg S.A., AstraZeneca Maroc SARLAU, AstraZeneca Nigeria Limited, AstraZeneca Nominees Limited, AstraZeneca Nordic AB, AstraZeneca OY., AstraZeneca PTY Limited, AstraZeneca Pars Company, AstraZeneca Peru S.A., AstraZeneca Pharma India Limited, AstraZeneca Pharma Poland Sp.z.o.o., AstraZeneca Pharma S.R.L., AstraZeneca Pharmaceutical (China) Co. Ltd, AstraZeneca Pharmaceuticals (Ireland) Designated Activity Company, AstraZeneca Pharmaceuticals (Phils.) Inc., AstraZeneca Pharmaceuticals (Pty) Limited, AstraZeneca Pharmaceuticals Aktiebolag, AstraZeneca Pharmaceuticals Co. Limited, AstraZeneca Pharmaceuticals LLC, AstraZeneca Pharmaceuticals LP, AstraZeneca Pharmaceuticals Limited, AstraZeneca Pharmaceuticals Pakistan (Private) Limited, AstraZeneca Pharmaceuticals Technologies (Beijing) Co. Ltd, AstraZeneca Produtos Farmaceuticos Lda, AstraZeneca Quest Limited, AstraZeneca Rho B.V., AstraZeneca S.A., AstraZeneca S.A. / N.V., AstraZeneca S.A. de C.V., AstraZeneca S.A.S., AstraZeneca Sdn Bhd, AstraZeneca Share Trust Limited, AstraZeneca Sigma B.V., AstraZeneca Singapore Pte Limited, AstraZeneca SpA, AstraZeneca Sweden Investments Limited, AstraZeneca Södertälje 2 AB, AstraZeneca Taiwan Limited, AstraZeneca Treasury B.V., AstraZeneca Treasury Limited, AstraZeneca Tunisie SaRL, AstraZeneca UK Limited, AstraZeneca US Investments Limited, AstraZeneca Ukraina LLC, AstraZeneca Venezuela S.A., AstraZeneca Vietnam Company Limited, AstraZeneca Zeta B.V, AstraZeneca d.o.o, AstraZeneca do Brasil Limitada, AstraZeneca Österreich GmbH, Atkemix Nine Inc., Atkemix Ten Inc., BMS Holdco Inc., Cambridge Antibody Technology, Cambridge Antibody Technology Group Limited, Centus Biotherapeutics Limited, Corpus Christi Holdings Inc., Definiens GmbH, Definiens Inc., Drimex LLC, Gotland Pharma S.A., Guangdong BeiKang Pharmaceutical Company Ltd, IPR Pharmaceuticals Inc., KuDOS Horsham Limited, KuDOS Pharmaceuticals Limited, KuDOS Pharmaceuticals Ltd, Laboratorio Beta S.A., Laboratorio Lailan S.A., Laboratorio Odin S.A., Laboratorio Tau S.A., MedImmune LLC, MedImmune Limited, MedImmune Pharma B.V, MedImmune U.K. Limited, MedImmune Ventures Inc, Montrose Chemical Corporation of California, Novastra Promoção e Comércio Farmacêutico Lda, Novastuart Produtos Farmaceuticos Lda, Novexel, Omthera Pharmaceuticals, Omthera Pharmaceuticals Inc., Optein Inc., P.T. AstraZeneca Indonesia, Pearl Therapeutics, Pearl Therapeutics Inc, Pharmaceutical Manufacturing Company Pty Limited, Pharmaceutical Manufacturing Division Pty Limited, SPA AstraZeneca Al Djazair, Simesa SpA, Sofotec GmbH, Spirogen Sarl, Stauffer Management Company LLC, Stuart Pharma Aktiebolag, Stuart-Produtos Farmacêuticos Lda, Symbicom Aktiebolag, Takeda Respiratory Business, Tika Lakemedel Aktiebolag, Trustee Limited, Unipessoal Lda, WuXi MedImmune Biopharmaceutical Co, ZS Pharma, ZS Pharma Inc, Zenco (No. 8) Limited, Zeneca Epsilon – Produtos Farmacêuticos Lda, Zeneca Finance (Netherlands) Company, Zeneca Holdings Inc., Zeneca Ilac Sanayi Ve Ticaret Anonim Sirketi, Zeneca Inc., Zeneca Wilmington Inc., and Zenecapharma Produtos Farmaceuticos .

When was AstraZeneca founded?

AstraZeneca was founded in 1999.

What is AstraZeneca's official website?

The official website for AstraZeneca is www.astrazeneca.com.

Where are AstraZeneca's headquarters?

AstraZeneca is headquartered at 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE X0, CB2 0AA.

How can I contact AstraZeneca?

AstraZeneca's mailing address is 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE X0, CB2 0AA. The company can be reached via phone at 44 20 3749 5000 or via email at [email protected]


This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.